RxDoctor Payments DataLook up a doctor →

Neerav Shah, MD

Cardiovascular Disease · Wellington, FLNPI 1144212770

Payments from drug & device makers

$2,080,650in general payments, 2019–2025

Across 1,786 payments — averaging $1164.98 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • American Regent$977K
  • Janssen Research & Development, LLC$565K
  • Boehringer Ingelheim International GmbH$190K
  • Novo Nordisk AS$178K
  • Boehringer Ingelheim Pharma GmbH & Co.kg$62K
  • Angiodynamics, Inc.$27K
  • plus $82K from 54 others

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
American Regent23$977,487
Janssen Research & Development, LLC64$565,211
Boehringer Ingelheim International GmbH146$189,690
Novo Nordisk AS450$177,587
Boehringer Ingelheim Pharma GmbH & Co.kg12$61,591
Angiodynamics, Inc.3$27,144
Cardiovascular Systems Inc.91$21,883
Novartis133$18,217
Atricure, Inc.40$6,019
Abbott72$5,582
Shockwave Medical, Inc29$3,529
Abiomed39$3,289
Medtronic(2 entities)42$2,520
Boston Scientific21$2,264
Penumbra, Inc.14$2,175
Cook Medical LLC59$2,022
Johnson & Johnson134$1,960
Philips North America LLC25$1,728
Boehringer Ingelheim63$1,698
Amgen67$1,390
Cvrx, Inc.20$1,366
AstraZeneca24$573
Bard Peripheral Vascular, Inc.17$532
Edwards Lifesciences4$453
Esperion Therapeutics, Inc.12$399
E.r. Squibb & Sons, L.L.C.30$379
Bayer18$368
Merck15$336
Amarin Pharma, Inc.22$313
Bolton Medical Inc3$271
Astellas Pharma US Inc7$243
Kestra Medical Technology Services, Inc.6$231
Heartflow, Inc.5$227
Chiesi USA, Inc.5$178
ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)11$176
Sanofi-aventis U.S. LLC4$175
Pfizer10$158
Cardiva Medical, Inc.4$143
Intuitive Surgical1$134
Cardiac Dimensions, Inc.1$132
Kiniksa Pharmaceuticals, Ltd.5$113
Surmodics, Inc.1$103
Silk Road Medical, Inc.2$77
Lexicon Pharmaceuticals, Inc.3$69
Kowa Pharmaceuticals America, Inc.3$61
Kvk-tech, Inc.6$55
Impulse Dynamics (USA) Inc.1$52
Teleflex LLC2$52
GSK3$50
Novo Nordisk2$37
Cleerly, Inc.2$35
Kiniksa Pharmaceuticals International, PLC2$31
Arbor Pharmaceuticals, Inc.1$23
Braemar Manufacturing, LLC1$21
Agepha Pharma FZ LLC1$20
Inari Medical, Inc.1$19
Inspire Medical Systems, Inc.1$18
BD1$16
Biosense Webster, Inc.1$15
G Medical Diagnostic Services, Inc.1$11

How this compares

$2,080,650 in reported general payments places this provider in the 95th percentile of 1,740 cardiovascular disease providers in Florida.

See all cardiovascular disease providers in Florida →

Medicare billing

Part B allowed, 2024
$679,615
Medicare patients
772
Services billed
5,424

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Wellington

See the full list for Florida →

Where these figures come from

Is this you, or does something look wrong? →